Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2015

01-09-2015 | Short Report

Differences in intestinal metaplasia in Barrett’s esophagus patients in an ethnically diverse south London population

Authors: Rhys Hewett, Vivek Chhaya, Derek Chan, Jin-Yong Kang, Andrew Poullis

Published in: Indian Journal of Gastroenterology | Issue 5/2015

Login to get access

Abstract

Barrett’s esophagus (BE) is the replacement of any portion of the normal distal squamous epithelial mucosa by metaplastic columnar epithelium and is the only known precursor for esophageal adenocarcinoma. We undertook a study to identify ethnic differences for the presence of intestinal metaplasia (IM) in BE in patients in an ethnically diverse south London population. Retrospective analysis was done using the endoscopy database of St George’s Hospital NHS Trust, which serves a large ethnically diverse London population. Gastroscopy records between 2009 and 2012 were retrieved, and patients with an endoscopic diagnosis of BE were identified. Patients of Indian subcontinent Asian origin (ISCA) were further identified. The presence of IM was retrieved from hospital pathology databases and was the primary outcome measured. Multivariate logistic regression analysis was performed to determine the odds of having IM by ethnic origin. ISCAs were 70 % less likely to have IM compared to non-ISCAs (OR 0.32, 95 % CI: 0.16–0.61, p = 0.001). This is the first study to identify differences in histological findings in ISCAs with BE living in the UK. Our findings may be useful for the future risk stratification of BE patients. Identification of environmental factors responsible for this difference would be of great therapeutic value.
Literature
1.
go back to reference Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastresophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol. 1997;92:27–31.PubMed Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastresophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol. 1997;92:27–31.PubMed
2.
go back to reference Sikkema M, de Jonge PJF, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–44. quiz e32.CrossRefPubMed Sikkema M, de Jonge PJF, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–44. quiz e32.CrossRefPubMed
3.
go back to reference Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237–49.CrossRefPubMed Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237–49.CrossRefPubMed
4.
go back to reference Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.CrossRefPubMed Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.CrossRefPubMed
5.
go back to reference Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s esophagus. Gut. 2014;63:7–42.CrossRefPubMed Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s esophagus. Gut. 2014;63:7–42.CrossRefPubMed
6.
go back to reference Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–57.PubMedCentralCrossRefPubMed Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–57.PubMedCentralCrossRefPubMed
7.
go back to reference Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99:1657–66.CrossRefPubMed Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99:1657–66.CrossRefPubMed
8.
go back to reference Hewett R, Chan D, Kang J-Y, Poullis A. New Barrett’s oesophagus surveillance guidelines: significant cost savings over the next 10 years on implementation. Frontline Gastroenterol. 2015;6:6–10.CrossRef Hewett R, Chan D, Kang J-Y, Poullis A. New Barrett’s oesophagus surveillance guidelines: significant cost savings over the next 10 years on implementation. Frontline Gastroenterol. 2015;6:6–10.CrossRef
9.
go back to reference Spechler S, Jain S, Tendler D. Racial differences in the frequency of symptoms and complications of gastro‐esophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795–800.CrossRefPubMed Spechler S, Jain S, Tendler D. Racial differences in the frequency of symptoms and complications of gastro‐esophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795–800.CrossRefPubMed
10.
go back to reference Abrams JA, Fields S, Lightdale CJ, Neugut AI. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–4.PubMedCentralCrossRefPubMed Abrams JA, Fields S, Lightdale CJ, Neugut AI. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–4.PubMedCentralCrossRefPubMed
11.
go back to reference Khoury JE, Chisholm S, Jamal MM, Palacio C, Pudhota S, Vega KJ. African Americans with Barrett’s esophagus are less likely to have dysplasia at biopsy. Dig Dis Sci. 2012;57:419–23.CrossRefPubMed Khoury JE, Chisholm S, Jamal MM, Palacio C, Pudhota S, Vega KJ. African Americans with Barrett’s esophagus are less likely to have dysplasia at biopsy. Dig Dis Sci. 2012;57:419–23.CrossRefPubMed
12.
go back to reference Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582–8.CrossRefPubMed Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582–8.CrossRefPubMed
13.
go back to reference El-Serag H, Mason A, Petersen N, Key C. Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–72.PubMedCentralCrossRefPubMed El-Serag H, Mason A, Petersen N, Key C. Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–72.PubMedCentralCrossRefPubMed
15.
go back to reference Balasubramanian G, Singh M, Gupta N, et al. Prevalence and predictors of columnar lined esophagus in gastresophageal reflux disease (GERD) patients undergoing upper endoscopy. Am J Gastroenterol. 2012;107:1655–61.CrossRefPubMed Balasubramanian G, Singh M, Gupta N, et al. Prevalence and predictors of columnar lined esophagus in gastresophageal reflux disease (GERD) patients undergoing upper endoscopy. Am J Gastroenterol. 2012;107:1655–61.CrossRefPubMed
16.
go back to reference Cameron AJ, Lomboy CT. Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992;103:1241–5.PubMed Cameron AJ, Lomboy CT. Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992;103:1241–5.PubMed
17.
go back to reference Corley DA, Buffler PA. Esophageal and gastric cardia adenocarcinomas : analysis of regional variation using the cancer incidence. Int J Epidemiol. 2001;30:1415–25.CrossRefPubMed Corley DA, Buffler PA. Esophageal and gastric cardia adenocarcinomas : analysis of regional variation using the cancer incidence. Int J Epidemiol. 2001;30:1415–25.CrossRefPubMed
18.
go back to reference Wood NJ. Genetics: driver genes are mutated early in the course of esophageal adenocarcinoma. Nat Rev Clin Oncol. 2014;11:439.CrossRefPubMed Wood NJ. Genetics: driver genes are mutated early in the course of esophageal adenocarcinoma. Nat Rev Clin Oncol. 2014;11:439.CrossRefPubMed
19.
go back to reference Kubo A, Cook MB, Shaheen NJ, et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. Gut. 2013;62:1684–91.CrossRefPubMed Kubo A, Cook MB, Shaheen NJ, et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. Gut. 2013;62:1684–91.CrossRefPubMed
20.
go back to reference Thavorn K, Mamdani MM, Straus SE. Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol. Syst Rev. 2014;3:71.PubMedCentralCrossRefPubMed Thavorn K, Mamdani MM, Straus SE. Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol. Syst Rev. 2014;3:71.PubMedCentralCrossRefPubMed
21.
go back to reference Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 2008;267:133–64.CrossRefPubMed Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 2008;267:133–64.CrossRefPubMed
22.
go back to reference Kang JY, Dhar A, Pollok R, et al. Diverticular disease of the colon: ethnic differences in frequency. Aliment Pharmacol Ther. 2004;19:765–9.CrossRefPubMed Kang JY, Dhar A, Pollok R, et al. Diverticular disease of the colon: ethnic differences in frequency. Aliment Pharmacol Ther. 2004;19:765–9.CrossRefPubMed
23.
go back to reference Murphy SJ, Johnston BT, Murray LJ. British Society of Gastroenterology guidelines for the diagnosis of Barrett’s esophagus: are we casting the net too wide? Gut. 2006;55:1821–2.PubMedCentralPubMed Murphy SJ, Johnston BT, Murray LJ. British Society of Gastroenterology guidelines for the diagnosis of Barrett’s esophagus: are we casting the net too wide? Gut. 2006;55:1821–2.PubMedCentralPubMed
24.
go back to reference Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–61.CrossRefPubMed Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–61.CrossRefPubMed
Metadata
Title
Differences in intestinal metaplasia in Barrett’s esophagus patients in an ethnically diverse south London population
Authors
Rhys Hewett
Vivek Chhaya
Derek Chan
Jin-Yong Kang
Andrew Poullis
Publication date
01-09-2015
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 5/2015
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-015-0597-9

Other articles of this Issue 5/2015

Indian Journal of Gastroenterology 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.